Who are Adicet Bio, Inc.'s main suppliers?

Adicet Bio, Inc. (ACET) key suppliers include: CRISPR Therapeutics AG, CRISPR Therapeutics AG, Twist Bioscience Corporation, Twist Bioscience Corporation, COHORT-PHARMACEUTICALS-INC and 1 more. View the full supplier network at chainsifter.com/chain/ACET.

Who are Adicet Bio, Inc.'s major customers?

Adicet Bio, Inc. (ACET) key customers include: CRISPR Therapeutics AG, CRISPR Therapeutics AG, CytoMed Therapeutics Limited, Regeneron Pharmaceuticals, Inc., Regeneron Pharmaceuticals, Inc. and 9 more. View the full customer network at chainsifter.com/chain/ACET.

What sector is Adicet Bio, Inc. in?

Adicet Bio, Inc. (ACET) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Adicet Bio, Inc. Supplier List (ACET): 6 Verified Suppliers

6Suppliers

14Customers

3Debt Items

20Related Chains

Source-Backed Evidence Depth

Adicet Bio, Inc. (ACET) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

25Total relationships

1Distinct source URLs

10High confidence

0.760Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Adicet Bio, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CRSP	CRISPR Therapeutics AG	90%	Reciprocal relationship from CRSP graph: Reciprocal relationship from ACET graph: The Company entered into a license and collaboration agreement with CRISPR Therapeutics AG (CRISPR Agreement) to non-…
CRSP	CRISPR Therapeutics AG	90%	The Company entered into a license and collaboration agreement with CRISPR Therapeutics AG (CRISPR Agreement) to non-exclusively license CRISPR’s gene editing technology (CRISPR Technology) for use i…
TWST	Twist Bioscience Corporation	90%	Reciprocal relationship from TWST graph: Reciprocal relationship from ACET graph: The Company will pay Twist an upfront, non-refundable project initiation fee, a technology access fee, as well as a p…
TWST	Twist Bioscience Corporation	90%	The Company will pay Twist an upfront, non-refundable project initiation fee, a technology access fee, as well as a project fee for each project entered into under the agreement.
COHORT-PHARMACEUTICALS-INC	COHORT-PHARMACEUTICALS-INC	85%	The Company may pay fees for development and regulatory milestones that together total in the single digit millions of dollars and sales milestones in the low-to-mid double digit millions of dollars.
GDTC	CytoMed Therapeutics Limited	72%	Reciprocal relationship from GDTC graph: Reciprocal relationship from ACET graph: Reciprocal relationship from GDTC graph: Reciprocal relationship from ACET graph: Reciprocal relationship from GDTC g…

Adicet Bio, Inc. Customers

Ticker	Name	Confidence	Evidence
CRSP	CRISPR Therapeutics AG	72%	ancial institution currently in receivership, if any of our lenders or counterparties to any such instruments were to be placed into receivership, we may be unable to access such funds. In addition, …
CRSP	CRISPR Therapeutics AG	72%	Reciprocal relationship from CRSP graph: Reciprocal relationship from ACET graph: Reciprocal relationship from CRSP graph: Reciprocal relationship from ACET graph: Reciprocal relationship from CRSP g…
GDTC	CytoMed Therapeutics Limited	72%	Reciprocal relationship from GDTC graph: l expansion. ATPL retained the right to use all products and/or services the Company creates which contain or incorporate the modified human K562 cells. Any n…
REGN	Regeneron Pharmaceuticals, Inc.	72%	f Shanghai Adicet from its then-stockholders (the Acquisition). In connection with the Acquisition, tax filings and registration were completed in August 2025. In August 2025, upon completion of the …
REGN	Regeneron Pharmaceuticals, Inc.	72%	Reciprocal relationship from REGN graph: Reciprocal relationship from ACET graph: f Shanghai Adicet from its then-stockholders (the Acquisition). In connection with the Acquisition, tax filings and r…
TWST	Twist Bioscience Corporation	72%	Reciprocal relationship from TWST graph: Reciprocal relationship from ACET graph: Reciprocal relationship from TWST graph: Reciprocal relationship from ACET graph: Reciprocal relationship from TWST g…
TWST	Twist Bioscience Corporation	72%	ancial institution currently in receivership, if any of our lenders or counterparties to any such instruments were to be placed into receivership, we may be unable to access such funds. In addition, …
DELAWARE-GENERAL-CORPORATION	DELAWARE-GENERAL-CORPORATION	62%	on waivers) should manufacturers fail to offer American consumers the most-favored-nation lowest price. It also directs the Secretary of Commerce and the U.S. Trade Representative to “take all necess…
GUGGENHEIM-SECURITIES-LLC	GUGGENHEIM-SECURITIES-LLC	62%	f Shanghai Adicet from its then-stockholders (the Acquisition). In connection with the Acquisition, tax filings and registration were completed in August 2025. In August 2025, upon completion of the …
SHANGHAI-ADICET-BIOTECHNOLOGY-CO-LTD	SHANGHAI-ADICET-BIOTECHNOLOGY-CO-LTD	62%	rced federal, state and foreign regulations. The occurrence of any of such problems could adversely impact the availability of products for our clinical trials and commercial sale. Furthermore, if co…
SHANGHAI-BIOTECHNOLOGY-CO-LTD	SHANGHAI-BIOTECHNOLOGY-CO-LTD	62%	rced federal, state and foreign regulations. The occurrence of any of such problems could adversely impact the availability of products for our clinical trials and commercial sale. Furthermore, if co…
SI	Shoulder Innovations, Inc.	62%	Reciprocal relationship from SI graph: Reciprocal relationship from ACET graph: velop or use AI systems that are governed by the AI Act, it may necessitate ensuring higher standards of data quality, …
SILVERGATE-CAPITAL-CORP	SILVERGATE-CAPITAL-CORP	62%	velop or use AI systems that are governed by the AI Act, it may necessitate ensuring higher standards of data quality, transparency, and human oversight, as well as adhering to specific and potential…
WESTPORT-OFFICE-PARK-LLC	WESTPORT-OFFICE-PARK-LLC	62%	owed by the Company under the CRISPR Agreement, and no milestones have been achieved. City of Hope On July 9, 2024, City of Hope (COH) and the Company entered into a license agreement (COH Agreement)…

Adicet Bio, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ACET-DEBT-7455	Warrants outstanding: 38.3984	90%	xbrl warrant detail from xbrl 2025-12-31.
ACET-DEBT	Debt stack $13.9M	90%	Market cache reports total debt of $13.9M.
ACET-DEBT-7456	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2020-12-31.

Adicet Bio, Inc. Acquisitions

Acquired Entity	Name	Confidence	Evidence
ACET-ACQ-0001720580-26-000023	Adicet Bio, Inc. issued a pre-funded warrant to acquire 250,000 shares of common stock.	85%	Adicet Bio, Inc. issued a pre-funded warrant to acquire 250,000 shares of common stock.

Adicet Bio, Inc. Ownership

Holder	Name	Confidence	Evidence
ACET-OWNER-BARCLAYS-PLC	BARCLAYS PLC	90%	13F overlay lists BARCLAYS PLC as top holder; 5 tracked holders.

Adicet Bio, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
IBIO	iBio, Inc.	100.00	2
KLRS	Kalaris Therapeutics, Inc.	100.00	2
GILD	Gilead Sciences, Inc.	100.00	2
SI	Shoulder Innovations, Inc.	100.00	1	['customer']
AUTL	Autolus Therapeutics plc	100.00	2
IPSC	Century Therapeutics, Inc.	100.00	2
ARTV	Artiva Biotherapeutics, Inc.	100.00	1	['spend']
TBPH	Theravance Biopharma, Inc.	100.00	2
IMTX	Immatics N.V.	100.00	2
EDSA	Edesa Biotech, Inc.	100.00	2
CHRS	Coherus Oncology, Inc.	100.00	2
REGN	Regeneron Pharmaceuticals, Inc.	100.00	1	['customer']
CRBU	Caribou Biosciences, Inc.	100.00	2
ALLO	Allogene Therapeutics, Inc.	100.00	2
BDRX	Biodexa Pharmaceuticals Plc	100.00	2
ALNY	Alnylam Pharmaceuticals, Inc.	100.00	2
CELU	Celularity Inc.	100.00	2
FATE	Fate Therapeutics, Inc.	100.00	2
GRAL	GRAIL, Inc.	100.00	2
TKPHF	Takeda Pharmaceutical Company Limited	100.00	2

Adicet Bio, Inc. Supply Chain